Market Cap 137.18B
Revenue (ttm) 28.75B
Net Income (ttm) 480.00M
EPS (ttm) N/A
PE Ratio 14.36
Forward PE 13.75
Profit Margin 1.67%
Debt to Equity Ratio 1.27
Volume 8,089,000
Avg Vol 6,948,730
Day's Range N/A - N/A
Shares Out 1.24B
Stochastic %K 59%
Beta 0.34
Analysts Strong Sell
Price Target $126.96

Company Profile

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis....

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 650 574 3000
Fax: 650 578 9264
Address:
333 Lakeside Drive, Foster City, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 2:39 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $GILD Current Share Price: $112.69 Contracts: $GILD January 15, 2027 $115 Calls Scale in: $12.71- $15.54 Scale out: $19.77-$25.43 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
stevenpierce
stevenpierce Oct. 3 at 6:51 PM
$GILD good size floor trade (+$500K) - all but certain BTO order
0 · Reply
skcots_13
skcots_13 Oct. 3 at 5:39 PM
$GILD is involved in unmet medical need. i tried drugs, and a little of something else. once killed a cockroach in my basement just to watch it die. that's why i'm bullish.
0 · Reply
scientificway
scientificway Oct. 3 at 2:12 PM
$GILD buy low. NAGE, no debt, guidance up. going up from here
0 · Reply
Power2k
Power2k Oct. 3 at 1:59 PM
$VKTX $MDGL Agree, BL should get someone to partner up with us on VK2809 even biopsies are demanded by FDA. We can't let MDGL to play monopoly in the MASH space. $GILD
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 1:32 PM
$GILD: Unusual Options Activity Alerted CALL flow observed 200x contracts at Strike price of $120 Exp on 11/21/2025 with Premium of $60K and showing BULLISH Sentiment
0 · Reply
RunnerSignals
RunnerSignals Oct. 3 at 11:29 AM
options jungle: smart money’s prowling! Bears circle $AEM $CRSP $GILD while bulls charge into $AVGO $ARQQ https://stocksrunner.com/news/2025-10-03-unusual-options-activity-alerts-smart-money-makes-bearish-bets
0 · Reply
BiotechBonesaw
BiotechBonesaw Oct. 2 at 11:57 PM
$ALT FYI Fourteen (14) other pharma companies kicked the tires on 89bio before Roche finalized the deal. Plenty of companies are looking at the space… $GILD makes a lot of sense 🚀
1 · Reply
TheGunnerAB
TheGunnerAB Oct. 2 at 8:56 PM
$CRVS It's strange to have a BP executive in small bio BOD. I saw it before but usually when the BP owns lots of shares, like $GILD and $RCUS There must be something bigger going on with announcement.
1 · Reply
AXMO
AXMO Oct. 2 at 8:27 PM
$MLTX $JNJ $PFE $GILD MASSIVE 🔥
1 · Reply
Latest News on GILD
Dividend Shields: Top 5 Income Stocks

Sep 30, 2025, 12:55 PM EDT - 4 days ago

Dividend Shields: Top 5 Income Stocks

ALEX LTC OMF THG


Hanmi's Oral Delivery Platform Compound Licensed to Gilead

Sep 29, 2025, 5:45 AM EDT - 5 days ago

Hanmi's Oral Delivery Platform Compound Licensed to Gilead


Gilead Sciences: Yeztugo And Trodelvy Make This A Buy Once More

Sep 23, 2025, 6:45 PM EDT - 10 days ago

Gilead Sciences: Yeztugo And Trodelvy Make This A Buy Once More


EU approves Gilead's new injection for preventing HIV

Aug 26, 2025, 3:03 AM EDT - 5 weeks ago

EU approves Gilead's new injection for preventing HIV


Gilead Sciences to Present at Upcoming Investor Conferences

Aug 20, 2025, 4:05 PM EDT - 6 weeks ago

Gilead Sciences to Present at Upcoming Investor Conferences


Final Trade: BSY, GDX, MNDY, GILD

Aug 11, 2025, 6:25 PM EDT - 7 weeks ago

Final Trade: BSY, GDX, MNDY, GILD

GDX MNDY BSY


Gilead Sciences Lifts Annual Outlook As Yeztugo Launch Nears

Aug 8, 2025, 10:55 AM EDT - 2 months ago

Gilead Sciences Lifts Annual Outlook As Yeztugo Launch Nears


Gilead Sciences, Inc. (GILD) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 9:39 PM EDT - 2 months ago

Gilead Sciences, Inc. (GILD) Q2 2025 Earnings Call Transcript


Gilead Sciences Q2: The New Drug That Could Change Everything

Aug 7, 2025, 7:26 PM EDT - 2 months ago

Gilead Sciences Q2: The New Drug That Could Change Everything


Gilead posts flat quarterly profit, raises full-year outlook

Aug 7, 2025, 4:25 PM EDT - 2 months ago

Gilead posts flat quarterly profit, raises full-year outlook


Gilead Sciences Announces Second Quarter 2025 Financial Results

Aug 7, 2025, 4:02 PM EDT - 2 months ago

Gilead Sciences Announces Second Quarter 2025 Financial Results


Trump pressures 17 pharma CEOs to cut US drug prices

Jul 31, 2025, 2:28 PM EDT - 2 months ago

Trump pressures 17 pharma CEOs to cut US drug prices

ABBV AMGN AZN BMY GSK JNJ LLY


Final Trades: Gilead, Blackstone, Disney and Visa

Jul 25, 2025, 1:25 PM EDT - 2 months ago

Final Trades: Gilead, Blackstone, Disney and Visa

BX DIS V


Calls of the Day: Gilead, Chipotle and P&G

Jul 25, 2025, 1:18 PM EDT - 2 months ago

Calls of the Day: Gilead, Chipotle and P&G

CMG PG


LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 4 at 2:39 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $GILD Current Share Price: $112.69 Contracts: $GILD January 15, 2027 $115 Calls Scale in: $12.71- $15.54 Scale out: $19.77-$25.43 Can Easily Capture: 60% ROI Blended DTE: 469 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
stevenpierce
stevenpierce Oct. 3 at 6:51 PM
$GILD good size floor trade (+$500K) - all but certain BTO order
0 · Reply
skcots_13
skcots_13 Oct. 3 at 5:39 PM
$GILD is involved in unmet medical need. i tried drugs, and a little of something else. once killed a cockroach in my basement just to watch it die. that's why i'm bullish.
0 · Reply
scientificway
scientificway Oct. 3 at 2:12 PM
$GILD buy low. NAGE, no debt, guidance up. going up from here
0 · Reply
Power2k
Power2k Oct. 3 at 1:59 PM
$VKTX $MDGL Agree, BL should get someone to partner up with us on VK2809 even biopsies are demanded by FDA. We can't let MDGL to play monopoly in the MASH space. $GILD
0 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 1:32 PM
$GILD: Unusual Options Activity Alerted CALL flow observed 200x contracts at Strike price of $120 Exp on 11/21/2025 with Premium of $60K and showing BULLISH Sentiment
0 · Reply
RunnerSignals
RunnerSignals Oct. 3 at 11:29 AM
options jungle: smart money’s prowling! Bears circle $AEM $CRSP $GILD while bulls charge into $AVGO $ARQQ https://stocksrunner.com/news/2025-10-03-unusual-options-activity-alerts-smart-money-makes-bearish-bets
0 · Reply
BiotechBonesaw
BiotechBonesaw Oct. 2 at 11:57 PM
$ALT FYI Fourteen (14) other pharma companies kicked the tires on 89bio before Roche finalized the deal. Plenty of companies are looking at the space… $GILD makes a lot of sense 🚀
1 · Reply
TheGunnerAB
TheGunnerAB Oct. 2 at 8:56 PM
$CRVS It's strange to have a BP executive in small bio BOD. I saw it before but usually when the BP owns lots of shares, like $GILD and $RCUS There must be something bigger going on with announcement.
1 · Reply
AXMO
AXMO Oct. 2 at 8:27 PM
$MLTX $JNJ $PFE $GILD MASSIVE 🔥
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 2 at 7:38 PM
Enter: $GILD OCT 24 2025 $110 CALLS Buy in Price: $3.60 - $4.05 Take Profit: $9.88 Stop Bleeding: $3.56 ROI Potential: 144% Exit Within: 336 Minutes https://moneygroup.us/alerts
0 · Reply
skcots_13
skcots_13 Oct. 2 at 7:36 PM
$GILD on a side note here, bitch please....
0 · Reply
MidnightMadness
MidnightMadness Oct. 2 at 3:40 PM
$GILD ...and Pfizer set a playbook approach on negotiation solutions.
0 · Reply
MidnightMadness
MidnightMadness Oct. 2 at 3:38 PM
$GILD Adding here.....PE=13, pipeline is robust. This is nervous energy on pricing impact from govt. Pfizer worked out a deal....Gild will do so as well -> what is notable is the sizable mfg they are building in the USA...and exactly what Trump desires so they have some negotation room.
0 · Reply
Reanimated666
Reanimated666 Oct. 2 at 3:00 PM
$GILD Why?
0 · Reply
topstockalerts
topstockalerts Oct. 2 at 2:11 PM
Gilead Sciences’ stock is recovering after a decade of underperformance, fueled by its strong HIV and oncology franchises and a more diversified business model. The company recently raised its sales guidance, with analysts projecting a 75% rise in earnings per share and gross margins above 83%. Whereas over 90% of revenue came from hepatitis C drugs like Sovaldi and Harvoni in 2015, liver disease now accounts for just 10% of sales, HIV treatments make up about two-thirds, and oncology has more than doubled since 2020. Gilead’s second-quarter results exceeded expectations, and management remains optimistic about the core HIV segment. Although the new HIV drug Yeztugo was launched too recently to impact quarterly results, early demand indicators are positive. Truist Securities upgraded the stock to Buy and raised the price target to $127 from $108, with shares recently trading at $111. With a 2026 P/E of 13 and a 2.8% dividend. $GILD
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 2 at 12:21 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $GILD Current Share Price: $111.15 Contracts: $GILD January 15, 2027 $115 Calls Scale in: $12.10- $14.79 Scale out: $18.83-$24.21 Can Easily Capture: 60% ROI Blended DTE: 471 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
EmSol
EmSol Oct. 2 at 11:48 AM
$GILD $RCUS they don’t need bid for Argus, they already finance then and own the portofolio
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 2 at 1:27 AM
Enter: $GILD OCT 24 2025 $112 CALLS Buy in Price: $3.40 - $3.60 Take Profit: $7.17 Stop Bleeding: $2.99 ROI Potential: 111% Exit Within: 93 Minutes https://moneygroup.us/alerts
0 · Reply
SweepCastApp
SweepCastApp Oct. 2 at 1:08 AM
$GILD: Unusual Options Activity Alerted CALL flow observed 10x contracts at Strike price of $75 Exp on 01/16/2026 with Premium of $38K and showing NEUTRAL Sentiment
0 · Reply
DefenseMania
DefenseMania Oct. 1 at 10:43 PM
$GILD will bid for $RCUS
1 · Reply
biolover
biolover Oct. 1 at 8:27 PM
$GILD $VKTX don’t know why Gilead keep coming as partner. ( which actually makes sense ). Any BP is possible. But this is least likely. Just listen to their CEO. Very boring. Although Bourla was barking for months and settled on little.
1 · Reply